Mandel-Brehm Josh
- SEC CIK
- 0001927058
In the past year, 1 open-market purchase filing worth $10.8K and no sales.
Current role at each company
- CAMP Camp4 Therapeutics CorpChief Executive Officeras of Aug 5, 2026
- PMN ProMIS Neurosciences Inc.Directoras of May 22, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- $10.8K
- 1 filing
- Sold
- –
- 0 filings
- Net
- +$10.8K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Mandel-Brehm Josh as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
CAMP Camp4 Therapeutics Corp
Chief Executive Officer2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 5, 2026 (view filing)5:07 PM ET | Aug 3 | 2 days | Mandel-Brehm JoshChief Executive Officer | PPurchase | +6.55K | $1.65 | +$10.8K | +2.4%285.0K after | |
| Sep 11, 2025 (view filing) | Sep 11 | Same day | Mandel-Brehm JoshChief Executive Officer | PPurchase | +6.06K | $1.65 | +$10.0K | +2.2%278.4K after |